Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
40,001
Total Claims
$1.1M
Drug Cost
541
Beneficiaries
$2,023
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-99%
Opioid rate vs peers
0.0% vs 2.2% avg
+43%
Cost per patient vs peers
$2,023 vs $1,411 avg
-12%
Brand preference vs peers
9.3% vs 10.6% avg
Brand vs Generic
Brand: 3,717 claims · $753K
Generic: 36,064 claims · $338K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,171 | $175K |
| Dulaglutide | 128 | $79K |
| Insulin Glargine,hum.Rec.Anlog | 215 | $69K |
| Linagliptin | 479 | $66K |
| Risperidone Microspheres | 21 | $26K |
| Vibegron | 173 | $21K |
| Sucroferric Oxyhydroxide | 23 | $20K |
| Liraglutide | 46 | $18K |
| Atorvastatin Calcium | 2,698 | $17K |
| Dapagliflozin Propanediol | 109 | $17K |
| Insulin Degludec | 46 | $17K |
| Insulin Lispro | 75 | $17K |
| Fluticasone/Umeclidin/Vilanter | 28 | $17K |
| Pimavanserin Tartrate | 14 | $16K |
| Umeclidinium Bromide | 65 | $16K |
Prescribing Profile
Patient Profile
79
Avg Age
65%
Female
2.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data